Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Legislation Likely To Recognize Pharmacist Services, NACDS Says

Executive Summary

NACDS' lobbying efforts for its SenioRxGold Medicare drug benefit proposal are likely to bring about the inclusion of pharmacist professional services in Medicare legislation, National Association of Chain Drug Stores Chairman Alan Levin told the association's annual meeting April 30 in Palm Beach, Fla.

You may also be interested in...



PhRMA "Beginning" To Recognize Drug Chains' Role In Healthcare - NACDS

NACDS has made progress in helping pharmaceutical manufacturers recognize drug store chains' role in healthcare, National Association of Chain Drug Stores Chairman Alan Levin told the association's annual meeting April 22 in Phoenix, Ariz.

PhRMA "Beginning" To Recognize Drug Chains' Role In Healthcare - NACDS

NACDS has made progress in helping pharmaceutical manufacturers recognize drug store chains' role in healthcare, National Association of Chain Drug Stores Chairman Alan Levin told the association's annual meeting April 22 in Phoenix, Ariz.

PBM Medicare Rx Contracts Would Last Five Years Under Democrat Proposal

Pharmacy benefit management contracts to administer a Medicare prescription drug benefit would run for five years under a proposal being considered by the House Democratic leadership for introduction the week of May 8.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel